Printable Prescription Pills Will be Safer and Faster-Acting July 16, 2010
Posted by Jeff Fuchs in manufacturing, new products and technologies, pharmaceutical.Tags: manufacturing, new products and technologies, pharmaceutical
add a comment
Printers seem to be able to do everything these days, including now the ability to print pills. GlaxoSmithKline has a developed a way of printing active ingredients onto tablets, a process that for the moment can be applied to only 0.5% of medicines in tablet form. The company, however, in collaboration with the University of Leeds and Durham University, hopes to increase that number to 40%. Because the pill’s active ingredients would be printed on the tablet’s surface, the pills would take effect much faster than dissolvable predecessors. Printing active ingredients would also mean precise doses.
Check out the GizMag article here.
Printable Prescription Pills Will be Safer and Faster-Acting July 16, 2010
Posted by Jeff Fuchs in manufacturing, new products and technologies, pharmaceutical.Tags: manufacturing, new products and technologies, pharmaceutical
add a comment
Printers seem to be able to do everything these days, including now the ability to print pills. GlaxoSmithKline has a developed a way of printing active ingredients onto tablets, a process that for the moment can be applied to only 0.5% of medicines in tablet form. The company, however, in collaboration with the University of Leeds and Durham University, hopes to increase that number to 40%. Because the pill’s active ingredients would be printed on the tablet’s surface, the pills would take effect much faster than dissolvable predecessors. Printing active ingredients would also mean precise doses.
Check out the GizMag article here.
Reworking the Pharma Supply Chain with Lean November 16, 2008
Posted by Jeff Fuchs in manufacturing, pharmaceutical, supply chain.Tags: manufacturing, pharmaceutical, supply chain
add a comment
According to IndustryWeek, there is a massive change in the manufacturing and supply chains at major pharmaceutical suppliers. At pharmaceutical giant Pfizer, Anthony J. Maddaluna is overseeing a massive overhaul of the company’s manufacturing and supply network worldwide.
The goal of the transformation? “For the longest time — and I think it’s been the model for most pharmaceutical companies — it was always ‘you sell what you make, you make what you sell,’” Maddaluna says. “What we’re doing now is an active transformation to become a globally competitive supply network. So, even though our name [PGM] says ‘manufacturing,’ it’s sort of a vestige of our name. We’re really a supply organization. We’ll be a very competitive ‘make or buy’ network. Our mission is to provide Pfizer with an innovative and powerful competitive advantage. That is the end goal.”
The article details how lean is being applied to the rationalization of factories and to the rejiggering of the supply chain design.
The full article is here.
Reworking the Pharma Supply Chain with Lean November 16, 2008
Posted by Jeff Fuchs in manufacturing, pharmaceutical, supply chain.Tags: manufacturing, pharmaceutical, supply chain
add a comment
According to IndustryWeek, there is a massive change in the manufacturing and supply chains at major pharmaceutical suppliers. At pharmaceutical giant Pfizer, Anthony J. Maddaluna is overseeing a massive overhaul of the company’s manufacturing and supply network worldwide.
The goal of the transformation? “For the longest time — and I think it’s been the model for most pharmaceutical companies — it was always ‘you sell what you make, you make what you sell,’” Maddaluna says. “What we’re doing now is an active transformation to become a globally competitive supply network. So, even though our name [PGM] says ‘manufacturing,’ it’s sort of a vestige of our name. We’re really a supply organization. We’ll be a very competitive ‘make or buy’ network. Our mission is to provide Pfizer with an innovative and powerful competitive advantage. That is the end goal.”
The article details how lean is being applied to the rationalization of factories and to the rejiggering of the supply chain design.
The full article is here.
